JPT2: A Promising Drug Target for Mathematical and Neurological Disorders

Target Name: JPT2

NCBI ID: G90861

JPT2

JPT2: A Promising Drug Target for Mathematical and Neurological Disorders

JPT2 (Java-like protein-2) is a 21-kDa protein that is expressed in various tissues of the brain, including the cerebral cortical cortical, cerebellum, and spinal cord. It is a member of the JPT family, which includes several similar proteins that play a crucial role in the development and maintenance of neuronal excitability and synaptic plasticity. The JPT family has been implicated in a wide range of neurological and mathematical disorders, including epilepsy, schizophrenia, and autism.

The discovery and characterization of JPT2

JPT2 was first identified as a protein that is expressed in the brain and is highly similar to the protein encoded by the gene JPT2. This protein is highly conserved, with a similar amino acid sequence to other members of the JPT family. The JPT2 protein is expressed in the brain and is involved in various physiological processes, including cell signaling, neurotransmitter release, and synaptic plasticity.

Functional characterization of JPT2

JPT2 has been shown to play a crucial role in several neurological and mathematical disorders. One of the most significant functions of JPT2 is its role in neurotransmitter release. JPT2 has been shown to play a role in the release of several neurotransmitters, including dopamine, serotonin, and nitric oxide. These neurotransmitters are involved in various physiological processes, including motor function, mood regulation, and memory.

In addition to its role in neurotransmitter release, JPT2 has also been shown to play a role in cell signaling. JPT2 has been shown to be involved in several signaling pathways, including the cAMP/PKA signaling pathway and the TGF-β signaling pathway. These signaling pathways are involved in various cellular processes, including cell growth, differentiation, and survival.

The potential therapeutic applications of JPT2

The therapeutic applications of JPT2 are vast and varied. One of the most promising applications of JPT2 is its potential as a drug target. JPT2 has been shown to play a role in the development and progression of several neurological and mathematical disorders, including epilepsy, schizophrenia, and autism. By targeting JPT2 with drugs, it may be possible to treat these disorders and improve the quality of life for patients.

In addition to its potential as a drug target, JPT2 may also be used as a biomarker for certain neurological disorders. The JPT2 protein is highly conserved and has been shown to be expressed in a variety of tissues, including the brain. By using JPT2 as a biomarker, it may be possible to diagnose and monitor the progression of certain neurological disorders.

Conclusion

JPT2 is a protein that has been identified as a potential drug target for several neurological and mathematical disorders. Its role in neurotransmitter release and cell signaling makes it an attractive target for drug development. In addition to its potential as a drug target, JPT2 may also be used as a biomarker for certain neurological disorders. Further research is needed to fully understand the functions of JPT2 and its potential as a therapeutic agent.

Protein Name: Jupiter Microtubule Associated Homolog 2

Functions: Nicotinic acid adenine dinucleotide phosphate (NAADP) binding protein required for NAADP-evoked intracellular calcium release (PubMed:33758061, PubMed:33758062). Confers NAADP-sensitivity to the two pore channels (TPCs) complex (PubMed:33758061). Enables NAADP to activate Ca(2+) release from the endoplasmic reticulum through ryanodine receptors (PubMed:33758062)

The "JPT2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about JPT2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets